Interim evaluation of British Patient Capital published
Today, the British Business Bank has published an interim evaluation of British Patient Capital (BPC). The evaluation, delivered by SQW, finds that British Patient Capital has helped create up to 5,000 additional jobs across the UK, driven company growth, and fuelled innovation through its investments.
British Patient Capital response to UK Venture Capital Financial Returns 2022 report
Venture capital is a long-term asset class. Whilst it is not immune from the challenges presented by a worsening macro-economic environment, one of the benefits of the venture capital model is its ability to deliver strong performance across cycles
British Patient Capital comments on the one-year anniversary of the launch of The Kalifa Review
The launch of the Kalifa Review in February last year was an important milestone in the development of the UK’s fintech sector, acknowledging both the important role the sector is playing in the economy and ensuring the UK can retain its position as the fintech capital of Europe.
The average value of a UK growth stage company reaches £100m in 2020, showing strong investor confidence
While the Small Business Equity Tracker Market examines the trends for UK smaller private companies raising capital, it doesn’t comment on the paucity of UK investors writing big checks for later stage funding rounds in the UK.
Foreign investors have long seen the opportunities. Today, Tech Nation revealed that in 2019 the UK led Europe for VC investment into Net Zero companies, at £336mn in VC investment which is up 28% on the previous year.
Q&A on the British Business Bank’s Equity Tracker 2019
The British Business Bank recently launched their 2019 Small Business Equity Tracker report. Our analysts Samuel Baldry and David Woods provide their insights on some of the key findings and what this means for British Patient Capital.